Clene Inc. (CLNN) vs Rani Therapeutics Holdings, Inc. (RANI)

A side-by-side comparison of Clene Inc. and Rani Therapeutics Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CLNN vs RANI

growth of $100 · dividends reinvested · last 5y
CLNN -97.7% (-53.1%/yr)RANI -93.0% (-41.2%/yr)RANI compounded faster over this window
0100200300Start $10020222023202420252026$2$7
CLNN RANI

CLNN vs RANI: by the numbers

  • •RANI is the larger company ($51M vs $51M market cap).
  • •Both run net losses; RANI's is the smaller (-618.02% vs -20059.90% net margin).
  • •RANI grew revenue faster over the past five years (9.95% vs -18.30% CAGR).

Metrics side by side

Valuation

MetricCLNNRANI
P/S ratio256.5410.54
P/B ratioN/A1.31

Profitability

MetricCLNNRANI
Gross margin78.50%44.89%
Operating margin-11541.50%-2345.99%
Net margin-20059.90%-618.02%
ROEN/A-76.82%
ROIC-109.13%-63.96%

Growth (annualized)

MetricCLNNRANI
Revenue CAGR (5Y)-18.30%9.95%
Total return CAGR (5Y)-51.16%-46.70%

Frequently asked

Which has grown faster, CLNN or RANI?
Over the past five years, RANI grew revenue faster — CLNN at a -18.30% CAGR versus RANI at 9.95%.
How have CLNN and RANI total returns compared?
Over the past 5 years, CLNN delivered -51.16% and RANI delivered -46.70% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.